(AOF) – In the first quarter, Virbac’s turnover stood at 345.7 million euros, up 9.8% at real rates compared to the same period of 2023. The specialist in animal health specifies that after restatement of the unfavorable impact resulting from the evolution of monetary parities, the growth in turnover over the period reached 10.8%. The integration of the Globion company acquired in India last November contributed 1.1 points of growth. Excluding acquisition and at constant exchange rates, revenue growth was 9.7%.
In 2024, at constant exchange rates and scope, Virbac forecasts growth in turnover estimated, at this stage, between 4% and 6% as well as a ratio of “current operating income, before amortization of assets resulting from acquisitions “(Adjusted Ebit) on “turnover” around 15%.
Excluding acquisitions, the cash position should improve by 30 million euros, taking into account the acceleration of R&D efforts as well as the investments planned over the period, estimated at around 100 million euros.
© 2024 Agence Option Finance (AOF) – All reproduction rights reserved by AOF. AOF collects its data from the sources it considers the safest. However, the reader remains solely responsible for their interpretation and use of the information made available to them. The reader must therefore hold AOF and its contributors harmless from any claim resulting from this use. Agence Option Finance (AOF) is a brand of the Option Finance group
Did you like this article ? Share it with your friends using the buttons below.
